Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Genotoxic Effects of New Azoloazine Derivatives with Antitumor Activity in MCF-7 Tumor Cell Culture
AU - Al-Humain, A. H.
AU - Speranskiy, D.
AU - Rybalkina, O.
AU - Sadchikova, E.
AU - Buldakov, M.
AU - Frolova, A.
AU - Cherdyntseva, N.
AU - Udut, V.
PY - 2023
Y1 - 2023
N2 - The genotoxic properties of three new azoloazine derivatives (azoloazines 1 – 3) exhibiting cytotoxic activity were studied in an in vitro experiment using MCF-7 human breast cancer cell culture. Acomparison of the effects of azoloazines 1 – 3 at doses of 1/2, 1/10, and 1/50 of IC50 with those of epirubicin at the same doses on the main indicators of damage to the genetic apparatus of the cells revealed that the studied compounds had the greatest toxic effect on DNAat a dose 1/10 of IC50. The genotoxicity of azoloazines 1 – 3 at a dose 1/10 of IC50 was shown to exceed that of epirubicin. © 2023, Springer Science+Business Media, LLC, part of Springer Nature.
AB - The genotoxic properties of three new azoloazine derivatives (azoloazines 1 – 3) exhibiting cytotoxic activity were studied in an in vitro experiment using MCF-7 human breast cancer cell culture. Acomparison of the effects of azoloazines 1 – 3 at doses of 1/2, 1/10, and 1/50 of IC50 with those of epirubicin at the same doses on the main indicators of damage to the genetic apparatus of the cells revealed that the studied compounds had the greatest toxic effect on DNAat a dose 1/10 of IC50. The genotoxicity of azoloazines 1 – 3 at a dose 1/10 of IC50 was shown to exceed that of epirubicin. © 2023, Springer Science+Business Media, LLC, part of Springer Nature.
UR - http://www.scopus.com/inward/record.url?partnerID=8YFLogxK&scp=85174246514
UR - https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=tsmetrics&SrcApp=tsm_test&DestApp=WOS_CPL&DestLinkType=FullRecord&KeyUT=001084566600003
U2 - 10.1007/s11094-023-02955-5
DO - 10.1007/s11094-023-02955-5
M3 - Article
VL - 57
SP - 822
EP - 827
JO - Pharmaceutical Chemistry Journal
JF - Pharmaceutical Chemistry Journal
SN - 0091-150X
IS - 6
ER -
ID: 48499386